In this episode of HIV Prevention in Action, host Cwayita Jemsana sits down with Nkosikhona "Uzzi" Mpungose, Founder and Director of Youth Inter-Active (YIA), public health advocate, and community leader, to discuss the role of youth activism in HIV prevention and social change.

We are incredibly proud to highlight a powerful new piece written by APHA co-founder Ntando Yola, recently published in Spotlight. Writing in the wake of the historic national launch of the twice-yearly lenacapavir injection in Secunda, Mpumalanga, Ntando reflects on what this milestone truly represents. It is not just a triumph of laboratory science, but a profound testament to the courage, time, and trust of ordinary young South Africans.

In this episode of HIV Prevention in Action, host Cwayita Jemsana sits down with youth leader and advocate Levi Singh to discuss the role of young people in shaping HIV prevention efforts, influencing policy conversations, and creating meaningful change in their communities and beyond.

The African Women Prevention Accountability Community Board (AWPACB) has joined global health advocates in celebrating the landmark launch of Lenacapavir in South Africa. While this long-acting HIV prevention drug represents a monumental shift in the HIV response, the AWPACB is raising critical concerns regarding the equity and accessibility of the current government rollout strategy.

Yvette Raphael, founder and director of Advocacy for the Prevention of HIV and AIDS (APHA), joined Newzroom Afrika to discuss the launch. Raphael shares vital insights into how the injection works, its localised side effects, and how it can alleviate daily "pill fatigue."

On 14th May, 2026, Yvette Raphael, found and director of APHA, delivered a speech at the UN General Assembly titled Delivering equitable, people-centered, and stigma-free HIV services across the continuum.

A new call to action from the Africa Women’s Prevention Community Accountability Board (AWPCAB) serves as a vital reminder: Access to health care is a human right, but choice is the engine of health equity. As new biomedical interventions like long-acting injectable PrEP become available, the public health community faces a challenge. It is not enough for these tools to exist; they must be accessible, affordable, and integrated into a system that respects the autonomy of t

A critical new report highlights how recent shifts in U.S. foreign policy are dismantling years of progress in South Africa’s fight against HIV. According to a report by Physicians for Human Rights (PHR), significant funding cuts from the United States are undermining the country's healthcare infrastructure at a pivotal moment. Key Takeaways from the Report: Wasted Investment: The U.S. previously funded approximately 17% of South Africa’s HIV budget. By abruptly slashing this

We are thrilled to share a powerful new interview featuring Yvette Raphael, the founder of Advocates for the Prevention of HIV in Africa (APHA). Recently, Yvette sat down with the team at Global Health Unfiltered for a deep dive into her 25-year journey as an advocate, the evolution of HIV prevention, and the critical need to put African women at the centre of clinical research.

Johannesburg, South Africa — 8 April 2026 Advocates for the Prevention of HIV in Africa (APHA ) welcomes the news that South Africa’s first consignment of long-acting lenacapavir for HIV prevention has arrived in the country . A twice-yearly injectable option has the potential to expand HIV prevention choices and support people who struggle to take a daily pill consistently. APHA also calls on government and partners to match this moment with urgency and clarity—so that the p

In a recent op-ed for The Independent, Yvette Raphael shared her deep concerns regarding the UK government’s decision to cut £900 million in bilateral aid to Africa. As a woman living with HIV in South Africa, Raphael knows that these are not just abstract policy shifts; they are life-and-death decisions that dismantle decades of hard-won progress.

dvocates for the Prevention of HIV in Africa (APHA) Executive Director and Co-Founder, Yvette Raphael, addressed high-level UK parliamentarians and global health leaders today, delivering a powerful call to action for inclusive science and equitable access to life-saving HIV prevention.

In a powerful debut episode of the HIV Prevention in Action podcast, public health leaders are calling for a shift in how we address the dual challenges of HIV and obesity. Released in observance of World Obesity Day (March 4), the episode features Yvette Raphael, Executive Director of APHA, and a globally recognised advocate for women living with HIV, who shares her personal and professional insights on the rising tide of non-communicable diseases (NCDs) within the HIV commu

As we close the chapter on 2025, I find myself reflecting on a year that tested us in ways we never anticipated, yet revealed the true strength of our community and the power of our collective resolve.

African women leaders and community advocates have issued a strong warning against any discussion or proposal to sunset the Joint United Nations Programme on HIV/AIDS (UNAIDS), stressing that the AIDS epidemic remains far from over.

Four leading African women’s health and HIV prevention organisations have hailed a landmark 53% reduction in the price of the monthly dapivirine vaginal ring - now set at $5.90. This announcement was made at the 23rd International Conference on AIDS and STIs in Africa (ICASA 2025) in Accra, Ghana.

At the recent TB Summit in Khayelitsha, Cape Town, public health leaders, community organisations, and government partners came together to reflect on South Africa’s progress in tackling TB and to confront the key barriers that remain. The Summit underscored the urgent need for approaches that address both the medical and social drivers of the epidemic.

The Global Black Gay Men Connect (GBGMC) and APHA applaud the landmark decision by the Government of South Africa and the South African Health Products Regulatory Authority (SAHPRA) to approve Lenacapavir (LEN) - a twice-yearly injectable HIV prevention treatment. This makes South Africa the first country on the African continent to register this breakthrough technology.

Advocates for the Prevention of HIV in Africa (APHA) applauds the South African Health Products Regulatory Authority (SAHPRA) for approving lenacapavir for HIV prevention. This milestone positions South Africa as a global leader in HIV prevention innovation and brings us significantly closer to ending the AIDS epidemic that has devastated our communities for over four decades.

In a powerful Member Blog published on 1 August 2025, Johanna Ralston (World Obesity Federation) and Yvette Raphael (Advocates for the...